Home LiteratureArticle Details
PMID: 7506410 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist.

Poli G, Kinter AL, Fauci AS

Abstract

In the present study we have observed that interleukin (IL) 1 alpha or IL-1 beta directly induced expression of human immunodeficiency virus (HIV) in the latently infected human promonocytic cell line U1. In addition, IL-1 synergized with IL-6, but not with tumor necrosis factor, in the upregulation of virus expression in U1 cells as measured by accumulation of steady-state mRNAs and production of reverse transcriptase activity. The HIV inductive effect of IL-1 was blocked by transforming growth factor beta, anti-IL-1 antibodies, or monoclonal antibodies directed to the type 1, but not to the type 2, cell surface receptor for IL-1; the latter actually caused enhancement of the IL-1-mediated effect. Unlike tumor necrosis factor alpha, IL-1 either alone or in combination with IL-6 did not induce activation of the transcription activating factor NF-kappa B above the constitutive levels of unstimulated U1 cells. Finally, the IL-1 receptor antagonist effectively blocked IL-1-mediated direct and synergistic inductive effects on virus production. Thus, IL-1 may be an important mediator of HIV expression, and blocking of IL-1 expression and/or its effects may have a potential therapeutic role in the inhibition of HIV expression in infected individuals.

MeSH Terms
Base Sequence Drug Synergism Gene Expression Regulation, Viral/drug effects HIV Reverse Transcriptase HIV-1/enzymology,growth & development Humans In Vitro Techniques Interleukin 1 Receptor Antagonist Protein Interleukin-1/pharmacology Interleukin-6/pharmacology Molecular Sequence Data NF-kappa B/metabolism Oligonucleotide Probes/chemistry RNA, Messenger/genetics RNA-Directed DNA Polymerase/metabolism Receptors, Interleukin-1/physiology Sialoglycoproteins/pharmacology Transforming Growth Factor beta/pharmacology Tumor Cells, Cultured Tumor Necrosis Factor-alpha/pharmacology Virus Replication/drug effects
Chemicals
IL1RN protein, human Interleukin 1 Receptor Antagonist Protein Interleukin-1 Interleukin-6 NF-kappa B Oligonucleotide Probes RNA, Messenger Receptors, Interleukin-1 Sialoglycoproteins Transforming Growth Factor beta Tumor Necrosis Factor-alpha HIV Reverse Transcriptase RNA-Directed DNA Polymerase
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Poli G
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Kinter A L
Fauci A S
References (35)
35 references, click to expand
  1. Interleukin 1 signaling occurs exclusively via the type I receptor.
    Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6155-9 PMID: 8327496
  2. p21ras contributes to HIV-1 activation in T-cells.
    FEBS Lett. 1992 Jun 15;304(2-3):261-4 PMID: 1535600
  3. Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis.
    Clin Exp Immunol. 1985 Oct;62(1):136-42 PMID: 2998656
  4. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.
    Science. 1987 Nov 6;238(4828):800-2 PMID: 3313729
  5. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.
    J Virol. 1988 Jan;62(1):139-47 PMID: 3257102
  6. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.
    Science. 1988 Feb 5;239(4840):617-22 PMID: 3277274
  7. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone.
    J Immunol. 1989 Jan 15;142(2):431-8 PMID: 2463307
  8. Purified blood monocytes from HIV 1-infected patients produce high levels of TNF alpha and IL-1.
    Clin Immunol Immunopathol. 1989 Mar;50(3):374-84 PMID: 2492910
  9. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.
    Proc Natl Acad Sci U S A. 1989 Apr;86(7):2336-40 PMID: 2494664
  10. Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid.
    J Neuroimmunol. 1989 Jul;23(2):109-16 PMID: 2656753
  11. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.
    Proc Natl Acad Sci U S A. 1989 Aug;86(15):5974-8 PMID: 2762307
  12. Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor.
    J Virol. 1989 Oct;63(10):4404-8 PMID: 2789293
  13. Effect of interleukin-1 on the augmentation of human immunodeficiency virus gene expression.
    Biochem Biophys Res Commun. 1989 Dec 15;165(2):715-21 PMID: 2480782
  14. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression.
    Proc Natl Acad Sci U S A. 1990 Jan;87(2):782-5 PMID: 2300561
  15. Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells.
    AIDS Res Hum Retroviruses. 1992 Apr;8(4):487-93 PMID: 1599755
  16. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages.
    J Clin Invest. 1992 Apr;89(4):1154-60 PMID: 1556179
  17. Role of cytokines in alveolar macrophage accessory cell function in HIV-infected individuals.
    J Immunol. 1992 Aug 15;149(4):1462-9 PMID: 1500725
  18. The role of monocyte/macrophages and cytokines in the pathogenesis of HIV infection.
    Pathobiology. 1992;60(4):246-51 PMID: 1388722
  19. Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-infected patients.
    Clin Exp Immunol. 1993 Jan;91(1):30-6 PMID: 8419083
  20. Independent binding of interleukin-1 alpha and interleukin-1 beta to type I and type II interleukin-1 receptors.
    J Biol Chem. 1993 Feb 5;268(4):2513-24 PMID: 8428929
  21. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.
    Int Rev Cytol. 1993;143:1-62 PMID: 8449662
  22. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.
    Nature. 1993 Mar 25;362(6418):355-8 PMID: 8455722
  23. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.
    Nature. 1993 Mar 25;362(6418):359-62 PMID: 8096068
  24. Macrophages and the human immunodeficiency virus.
    Immunol Today. 1990 Jun;11(6):217-23 PMID: 2191685
  25. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms.
    J Exp Med. 1990 Jul 1;172(1):151-8 PMID: 2193094
  26. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes.
    J Clin Invest. 1990 Jul;86(1):148-59 PMID: 2114424
  27. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.
    Nature. 1990 Dec 6;348(6301):550-2 PMID: 2147233
  28. Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage.
    J Exp Med. 1991 Mar 1;173(3):589-97 PMID: 1705278
  29. Epidermal interleukin 1 in normal skin of patients with HIV infection.
    Br J Dermatol. 1990 Oct;123(4):487-92 PMID: 2095180
  30. Effect of cytokines and lipopolysaccharides on HIV infection of human macrophages.
    Res Virol. 1991 Mar-Jun;142(2-3):197-204 PMID: 1716776
  31. Anti-CD2 receptor antibodies activate the HIV long terminal repeat in T lymphocytes.
    J Immunol. 1991 Oct 1;147(7):2290-4 PMID: 1680914
  32. Tumor necrosis factor-alpha, interleukin 1, and phorbol myristate acetate are independent activators of NF-kappa B which differentially activate T cells.
    Cytokine. 1991 Sep;3(5):372-9 PMID: 1751774
  33. Activation of cytokine genes in HIV-1 infected myelomonoblastic cells by phorbol ester and tumor necrosis factor.
    J Immunol. 1992 Feb 15;148(4):1222-9 PMID: 1371135
  34. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro.
    Immunol Today. 1991 Nov;12(11):404-10 PMID: 1838480
  35. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4.
    Science. 1993 Jul 23;261(5120):472-5 PMID: 8332913
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1994-01-04
Pages
108-12
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC42895
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com